Tumoricidal Effects of Macrophage-activating Immunotherapy in a Murine Model of Relapsed/ Refractory Multiple Myeloma

Myeloma remains a virtually incurable malignancy. The inevitable evolution of multi-drug resistant clones and widespread clonal heterogeneity limit the potential of traditional and novel therapies to eliminate minimal residual disease, a reliable harbinger of relapse. Here we show potent anti-myelom...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancer Immunol Res
Autores principales: Jensen, Jeffrey L., Rakhmilevich, Alexander, Heninger, Erika, Broman, Aimee Teo, Hope, Chelsea, Phan, Funita, Miyamoto, Shigeki, Maroulakou, Ioanna, Callander, Natalie, Hematti, Peiman, Chesi, Marta, Bergsagel, P. Leif, Sondel, Paul, Asimakopoulos, Fotis
Formato: Artigo
Lenguaje:Inglês
Publicado: 2015
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4527950/
https://ncbi.nlm.nih.gov/pubmed/25941352
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-15-0025-T
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares